Carregant...
Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives
Human cytomegalovirus (HCMV) infection is associated with severe morbidity and mortality in immunocompromised individuals, mainly transplant recipients and AIDS patients, and is the most frequent cause of congenital malformations in newborn children. To date, few drugs are licensed for the treatment...
Guardat en:
| Publicat a: | Pharmacol Ther |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier Inc.
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7112563/ https://ncbi.nlm.nih.gov/pubmed/21570424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2011.04.007 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|